Is dyschloremia a marker of critical illness or euchloremia an interventional target to improve outcomes?
Editorial Commentary

Is dyschloremia a marker of critical illness or euchloremia an interventional target to improve outcomes?

Fabrizio Canepa-Escaro1, Javier A. Neyra2

1Department of Internal Medicine, Division of Hospital Medicine, University of Kentucky Medical Center, Lexington, KY, USA; 2Department of Internal Medicine, Division of Nephrology, Bone and Mineral Metabolism, University of Kentucky Medical Center, Lexington, KY, USA

Correspondence to: Fabrizio Canepa-Escaro, MD, FACP; Javier A. Neyra, MD, MSCS. University of Kentucky Medical Center, 800 Rose St, MS 669, Lexington, KY 49536, USA. Email: fabriziocanepa@uky.edu; javier.neyra@uky.edu.

Provenance: This is an invited article commissioned by the Guest Section Editor Dr. Yibing Zhu (Department of Critical Care Medicine, Fuxing Hospital, Capital Medical University, Beijing, China).

Comment on: Shen Y, Yan J, Cai G, et al. Interaction between serum chloride increase and baseline chloride level. Intensive Care Med 2019;45:909-10.
Barhight MF, Brinton J, Stidham T, et al. Increase in chloride from baseline is independently associated with mortality in critically ill children. Intensive Care Med 2018;44:2183-91.


Submitted Nov 12, 2019. Accepted for publication Dec 02, 2019.

doi: 10.21037/atm.2019.12.48


Despite chloride being the most abundant extracellular anion, its significance in clinical practice was undervalued for years. In the past decade this has dramatically changed to the point of chloride receiving the distinction of “queen” of electrolytes (1); with several observational and interventional studies focused on the chloride content of crystalloid solutions used for fluid resuscitation.

For years, isotonic 0.9% saline has been the intravenous crystalloid of choice for fluid resuscitation despite its supraphysiologic content of chloride in relation to plasma, its acidic pH, and the absence of other electrolyte content similar to plasma (2). Importantly, murine models of sepsis showed that the use of 0.9% saline for resuscitation caused hyperchloremic metabolic acidosis, increment in pro-inflammatory cytokines such as IL-6, increased nitric oxide release and NF-κB DNA binding, which was attenuated by the use of more balanced crystalloids with less content of chloride (3,4). Furthermore, incident acute hyperchloremia has been linked to increased risk of acute kidney injury (AKI), mediated by distal tubular chloride delivery affecting tubule-glomerular feedback and the imbalance between vasodilatory prostaglandin E2 and vasoconstrictive thromboxane A2 synthesis, thus causing vasoconstriction and ultimately decreasing renal blood flow (5).

Following pre-clinical evidence, several clinical studies focused on comparing balanced solutions (chloride restrictive approaches) vs. non-balanced solutions (chloride liberal approaches) (6-8). These studies showed that chloride-rich solutions are associated with increased mortality and less consistently with end-organ injury (e.g., AKI). Additionally, observational studies in humans confirmed the relationship of high chloride intravenous load and/or hyperchloremia with adverse outcomes in critically ill patients, including mortality and AKI (9-11). More conclusively, two recent large randomized clinical trials (SALT-ED and SMART) (12,13) both demonstrated benefit of balanced solutions over isotonic 0.9% saline as resuscitation fluids for the risk of major adverse kidney events (MAKE). Critically ill adults that received balanced solutions as intravenous resuscitation fluids had less frequent MAKE compared to those receiving 0.9% saline [14.3% vs. 15.4%, OR 0.91 (95% CI, 0.84–0.99); P=0.04]. Similarly, in non-critically ill patients, there was an advantage of balanced solutions over 0.9% saline (4.7% vs. 5.6% incident MAKE, OR 0.82 (95% CI, 0.70–0.95); P=0.01] (12,13). These studies somehow ended the resilience to the utilization of chloride-restrictive approaches for fluid resuscitation, and emphasized the need for implementing the more frequent use of balanced solutions for fluid resuscitation in the intensive care unit (ICU) and non-ICU settings.

In critically ill children, hyperchloremia has also been associated with AKI and increased mortality (14,15). Barhight et al. performed a retrospective single-center cohort study of critically ill children to examine the relationship of admission levels of serum chloride and change in serum chloride levels (<5 vs. ≥5 mmol/L) on the first day of ICU stay with hospital mortality (16). After adjusting for measured confounders, they found that increment in serum chloride of ≥5 mmol/L associates with a 2.3 (95% CI, 1.03–5.21) higher odds of mortality. Importantly, they reported a higher mortality rate in those already hyperchloremic on admission (≥110 mmol/L) in comparison to those with normochloremia (96–109 mmol/L) and hypochloremia (<96 mmol/L) on admission (40% vs. 11% vs. 6% for those with ≥5 mmol/L increase in serum chloride levels on the first day of ICU stay, respectively). This observation parallels the study by Neyra et al. (9) examining a cohort of critically ill septic adults, in which worsening hyperchloremia (every 5 mmol/L increment in serum chloride within the first 72 h of ICU stay) in those patients already hyperchloremic on admission independently associated with hospital mortality [adjusted OR 1.37 (95% CI, 1.11–1.69); P=0.003].

In a commentary related to the work by Barhight et al., Shen et al. raised the concern of interpreting increment in serum chloride levels without addressing the potential interaction with baseline levels on admission (17). Using the MIMIC III database, they reported a bidirectional relationship between increment in serum chloride levels and mortality, highlighting its association with decreased mortality in patients with hypochloremia (serum chloride <85 mmol/L perhaps hypovolemic) and increased mortality in those with hyperchloremia (perhaps hypervolemic) on admission. Moreover, they report that worsening hyperchloremia exhibits a dose-response direct effect on mortality. This bidirectional relationship was likely not observed in the work by Barhight et al. due to the low number of children with hypochloremia on admission. It is possible that patients with hypochloremia may be hypovolemic (chloride “avid”) and that restoring euchloremia may be equally beneficial as avoiding worsening hyperchloremia in their counterparts. It is also important to remark that a possible explanation for this interaction is that serum chloride levels on ICU admission represent not only the volume status of the patient but the pre-ICU type and amount of intravenous fluids administered, which becomes relevant for patients transferred from other facilities or with a prolonged hospitalization before admission to the ICU. Despite Barhight et al. adjusting for total fluid volume in the first 24 h in the multivariable analysis, pre-ICU fluid administration/fluid overload was not quantified.

Hypochloremia has also been linked to increased mortality and organ dysfunction in patients with heart failure and in heterogeneous critically ill populations (18,19). Shao et al. conducted a retrospective cohort study of 6025 critically ill adults and found that dyschloremia (both hypochloremia and hyperchloremia) is associated with AKI (20). Patients with hypochloremia (<100 mmol/L) and hyperchloremia (>108 mmol/L) had a higher incidence of AKI compared to normochloremic patients (43% vs. 30%, P=0.006 and 34% vs. 30%, respectively; P<0.001). Additionally, hypochloremic patients had higher mortality and longer length of hospital stay compared to those without hypochloremia. In a different study, Oh et al. examined temporal change of serum chloride levels in a heterogeneous ICU population and found that decrements in chloride levels by 1 mmol/L within 72 h of ICU stay were associated with a 4% increased odds of developing AKI at the same timepoint (21). This observation was also consistent in a subgroup of patients in which decrements in chloride levels were associated with increased levels of cystatin C, a marker of kidney dysfunction. Unfortunately, the three-way interaction between admission levels, change in serum chloride levels, and outcome was not examined in this study.

Despite evolving research on this topic, the debate on the type (and amount) of fluid therapy to be given to the right patient at the right time is still ongoing. In the era of precision medicine, a pH-guided approach of fluid resuscitation has been proposed in the ICU scientific community and deserves consideration (22). This approach consists of favoring isotonic 0.9% saline for patients with hypovolemia and metabolic alkalosis (a common reason for hypochloremia); balanced crystalloids for patients with no major pH abnormalities; and the use of isotonic bicarbonate for patients with severe non-anion gap metabolic acidosis and/or anion gap metabolic acidosis due to uremia. Nonetheless, the disadvantage of this approach is the possibility of multiple interrelated acid-base disorders with distinct pathobiological triggers in critically ill patients with multi-organ failure. Furthermore, use of isotonic bicarbonate conveys other problems related to hyperosmolarity, carbon dioxide retention with intracellular acidosis, hypocalcemia and hypokalemia (23). In this context, after the increasing evidence that dyschloremias may have negative clinical outcomes; we propose a more practical approach of chloride-guided fluid resuscitation aiming for euchloremia (Figure 1). Importantly, these are theoretical approaches that need to be rigorously and systematically tested in properly designed interventional studies.

Figure 1 Theoretical approach of chloride-guided fluid resuscitation to achieve or maintain euchloremia. The critical first step is to determine if the patient requires and/or responds to intravenous fluids. Importantly, fluid therapy should be stopped when the patient is no longer fluid responsive. If the patient requires intravenous fluid therapy, proceed with a chloride-guided fluid resuscitation approach aiming for euchloremia: (I) if the patient is hypochloremic, administer isotonic 0.9% saline. When normochloremia is achieved and if intravenous fluids are still needed, transition to balanced solutions unless there are relative contraindications to consider (e.g., hypercalcemia, incompatibility with medications, etc.); (II) if the patient is euchloremic, favor balanced solutions to maintain euchloremia; (III) if the patient is hyperchloremic, favor balanced solutions or consider isotonic bicarbonate (the later only if pH is <7.20 and/or serum bicarbonate <12 mmol/L and if strict monitoring of electrolytes is available), otherwise continue balanced solutions to prevent worsening hyperchloremia.

In summary, the past decade has underpinned a surge of evidence supporting the association of dyschloremia with increased mortality and possibly AKI. Worsening hyperchloremia has been consistently associated with worse outcomes in heterogeneous critically ill populations whilst “correcting” hypochloremia (restoring euchloremia) can favor positive outcomes. Therefore, serum chloride levels constitute a relevant and dynamic clinical parameter to guide fluid therapy during acute illness. Though we acknowledge that fluid therapy should be individualized (e.g., timing, type, amount, etc.) according to specific patient needs and fluid responsiveness, an initial approach could be tailored to restoring or maintaining euchloremia.


Acknowledgments

Funding: Dr. Neyra is currently supported by an Early Career Pilot Grant from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through Grant UL1 TR001998.


Footnote

Conflicts of Interest: The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.


References

  1. Berend K, van Hulsteijn LH, Gans RO. Chloride: the queen of electrolytes? Eur J Intern Med 2012;23:203-11. [Crossref] [PubMed]
  2. Semler MW, Kellum JA. Balanced Crystalloid Solutions. Am J Respir Crit Care Med 2019;199:952-60. [Crossref] [PubMed]
  3. Kellum JA, Song M, Li J. Lactic and hydrochloric acids induce different patterns of inflammatory response in LPS-stimulated RAW 264.7 cells. Am J Physiol Regul Integr Comp Physiol 2004;286:R686-92. [Crossref] [PubMed]
  4. Zhou F, Peng ZY, Bishop JV, et al. Effects of fluid resuscitation with 0.9% saline versus a balanced electrolyte solution on acute kidney injury in a rat model of sepsis*. Crit Care Med 2014;42:e270-8. [Crossref] [PubMed]
  5. Rein JL, Coca SG. "I don't get no respect": the role of chloride in acute kidney injury. Am J Physiol Renal Physiol 2019;316:F587-F605. [Crossref] [PubMed]
  6. Raghunathan K, Shaw A, Nathanson B, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*. Crit Care Med 2014;42:1585-91. [Crossref] [PubMed]
  7. Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012;308:1566-72. [Crossref] [PubMed]
  8. Young P, Bailey M, Beasley R, et al. Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial. JAMA 2015;314:1701-10. [Crossref] [PubMed]
  9. Neyra JA, Canepa-Escaro F, Li X, et al. Association of Hyperchloremia With Hospital Mortality in Critically Ill Septic Patients. Crit Care Med 2015;43:1938-44. [Crossref] [PubMed]
  10. Suetrong B, Pisitsak C, Boyd JH, et al. Hyperchloremia and moderate increase in serum chloride are associated with acute kidney injury in severe sepsis and septic shock patients. Crit Care 2016;20:315. [Crossref] [PubMed]
  11. Shaw AD, Raghunathan K, Peyerl FW, et al. Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med 2014;40:1897-905. [Crossref] [PubMed]
  12. Self WH, Semler MW, Wanderer JP, et al. Balanced Crystalloids versus Saline in Noncritically Ill Adults. N Engl J Med 2018;378:819-28. [Crossref] [PubMed]
  13. Semler MW, Self WH, Wanderer JP, et al. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med 2018;378:829-39. [Crossref] [PubMed]
  14. Barhight MF, Lusk J, Brinton J, et al. Hyperchloremia is independently associated with mortality in critically ill children who ultimately require continuous renal replacement therapy. Pediatr Nephrol 2018;33:1079-85. [Crossref] [PubMed]
  15. Stenson EK, Cvijanovich NZ, Anas N, et al. Hyperchloremia Is Associated With Complicated Course and Mortality in Pediatric Patients With Septic Shock. Pediatr Crit Care Med 2018;19:155-60. [Crossref] [PubMed]
  16. Barhight MF, Brinton J, Stidham T, et al. Increase in chloride from baseline is independently associated with mortality in critically ill children. Intensive Care Med 2018;44:2183-91. [Crossref] [PubMed]
  17. Shen Y, Yan J, Cai G, et al. Interaction between serum chloride increase and baseline chloride level. Intensive Care Med 2019;45:909-10. [Crossref] [PubMed]
  18. Hanberg JS, Rao V, Ter Maaten JM, et al. Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights. Circ Heart Fail 2016. [Crossref] [PubMed]
  19. Kimura S, Matsumoto S, Muto N, et al. Association of serum chloride concentration with outcomes in postoperative critically ill patients: a retrospective observational study. J Intensive Care 2014;2:39. [Crossref] [PubMed]
  20. Shao M, Li G, Sarvottam K, et al. Dyschloremia Is a Risk Factor for the Development of Acute Kidney Injury in Critically Ill Patients. PLoS One 2016;11:e0160322. [Crossref] [PubMed]
  21. Oh TK, Song IA, Jeon YT, et al. Fluctuations in Serum Chloride and Acute Kidney Injury among Critically Ill Patients: A Retrospective Association Study. J Clin Med 2019. [Crossref] [PubMed]
  22. Farkas J. PulmCrit: pH-guided fluid resuscitation & BICAR-ICU. 2018, June 27. [cited 30 September 2019].Available online: https://emcrit.org/pulmcrit/bicar-icu/
  23. Adeva-Andany MM, Fernandez-Fernandez C, Mourino-Bayolo D, et al. Sodium bicarbonate therapy in patients with metabolic acidosis. ScientificWorldJournal 2014;2014:627673. [Crossref] [PubMed]
Cite this article as: Canepa-Escaro F, Neyra JA. Is dyschloremia a marker of critical illness or euchloremia an interventional target to improve outcomes? Ann Transl Med 2019;7(Suppl 8):S264. doi: 10.21037/atm.2019.12.48